136 related articles for article (PubMed ID: 2993411)
1. Surface marker characterization of EBV target cells in normal blood and tonsil B lymphocyte populations.
Aman P; Gordon J; Lewin N; Nordström M; Ehlin-Henriksson B; Klein G; Carstensson A
J Immunol; 1985 Oct; 135(4):2362-7. PubMed ID: 2993411
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of EBV-transformable human B lymphocyte populations.
Chan MA; Stein LD; Dosch HM; Sigal NH
J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells].
Koizumi S
Hokkaido Igaku Zasshi; 1985 Sep; 60(5):724-34. PubMed ID: 3000906
[TBL] [Abstract][Full Text] [Related]
4. BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus.
Thorley-Lawson DA; Nadler LM; Bhan AK; Schooley RT
J Immunol; 1985 May; 134(5):3007-12. PubMed ID: 2984280
[TBL] [Abstract][Full Text] [Related]
5. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
Klein G; Ehlin-Henriksson B; Schlossman SF
J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
[TBL] [Abstract][Full Text] [Related]
6. Phenotype, frequency, and EBV responsiveness of human marrow B and pre-B cells.
Hibi T; Chan MA; Petsche D; Dosch HM
J Immunol; 1986 May; 136(9):3211-8. PubMed ID: 3007613
[TBL] [Abstract][Full Text] [Related]
7. Changes in the phenotype and immunoglobulin secretion of human B cells following co-culture with cells of an EBV+ lymphoblastoid line or fusion with mouse plasmacytoma cells. Studies in short-term and long-term culture.
Ling NR; Lowe JA
Clin Exp Immunol; 1989 Feb; 75(2):311-6. PubMed ID: 2539279
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus preferentially induces proliferation of primed B cells.
Crain MJ; Sanders SK; Butler JL; Cooper MD
J Immunol; 1989 Sep; 143(5):1543-8. PubMed ID: 2547870
[TBL] [Abstract][Full Text] [Related]
9. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
Yokochi T; Holly RD; Clark EA
J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
[TBL] [Abstract][Full Text] [Related]
10. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells.
Kryworuckho M; Diaz-Mitoma F; Kumar A
Immunology; 1995 Sep; 86(1):41-8. PubMed ID: 7590880
[TBL] [Abstract][Full Text] [Related]
11. A new antigen identified by the monoclonal antibody UCHB 1 delivers a costimulatory signal to a subset of human B cells.
Armitage RJ; Rowe DJ; Beverly PC
Eur J Immunol; 1988 Jan; 18(1):67-76. PubMed ID: 3257923
[TBL] [Abstract][Full Text] [Related]
12. Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype.
Gregory CD; Tursz T; Edwards CF; Tetaud C; Talbot M; Caillou B; Rickinson AB; Lipinski M
J Immunol; 1987 Jul; 139(1):313-8. PubMed ID: 2953817
[TBL] [Abstract][Full Text] [Related]
13. Isolation and functional analysis of human B cell populations. I. Characterization of the B1+B2+ and B1+B2- subsets.
Anderson KC; Boyd AW; Fisher DC; Slaughenhoupt B; Groopman JE; O'Hara CJ; Daley JF; Schlossman SF; Nadler LM
J Immunol; 1985 Feb; 134(2):820-7. PubMed ID: 3917476
[TBL] [Abstract][Full Text] [Related]
14. Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype.
Welsh RM; Haspel MV; Parker DC; Holmes KV
J Immunol; 1986 Feb; 136(4):1454-60. PubMed ID: 3003199
[TBL] [Abstract][Full Text] [Related]
15. Patterns of isotype commitment in human B cells: limiting dilution analysis of Epstein Barr virus-infected cells.
Stein LD; Ledgley CJ; Sigal NH
J Immunol; 1983 Apr; 130(4):1640-5. PubMed ID: 6300231
[TBL] [Abstract][Full Text] [Related]
16. Relationship between immunoglobulin production and immortalization by Epstein Barr virus.
Tosato G; Blaese RM; Yarchoan R
J Immunol; 1985 Aug; 135(2):959-64. PubMed ID: 2989369
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
Tseng CT; Springgate CF; Piela TH; Choi YS
J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
[TBL] [Abstract][Full Text] [Related]
18. Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue.
Campana D; Janossy G; Bofill M; Trejdosiewicz LK; Ma D; Hoffbrand AV; Mason DY; Lebacq AM; Forster HK
J Immunol; 1985 Mar; 134(3):1524-30. PubMed ID: 3918103
[TBL] [Abstract][Full Text] [Related]
19. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus susceptibility of normal human B lymphocyte populations.
Aman P; Ehlin-Henriksson B; Klein G
J Exp Med; 1984 Jan; 159(1):208-20. PubMed ID: 6319530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]